MiR‐146a‐5p correlates with clinical efficacy in patients with psoriasis treated with the tumour necrosis factor‐alpha inhibitor adalimumab

Saved in:
Bibliographic Details
Published inBritish journal of dermatology (1951) Vol. 179; no. 3; pp. 787 - 789
Main Authors Mensà, E., Recchioni, R., Marcheselli, F., Giuliodori, K., Consales, V., Molinelli, E., Prattichizzo, F., Rippo, M. R., Campanati, A., Procopio, A.D., Olivieri, F., Offidani, A.M.
Format Journal Article
LanguageEnglish
Published England Oxford University Press 01.09.2018
Subjects
Immunotherapy
Monoclonal antibodies
Necrosis
TNF inhibitors
Online AccessGet full text
ISSN0007-0963
1365-2133
1365-2133
DOI10.1111/bjd.16659

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
ObjectType-Correspondence-3
content type line 23
ISSN:0007-0963
1365-2133
1365-2133
DOI:10.1111/bjd.16659